InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-9.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Farmakis Peter, Président. Director active across 2 companies, notably JELD-WEN Holding, Inc.. Aggregated, 4 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €249k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 6 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
52,240 shares@ US$6.740.23% mcap35.2% of flowCommon StockSEC:0001674335-21-000092:0
52,240 shares@ US$6.7435.2% of flowCommon StockSEC:0001674335-21-000092
5,336 shares@ US$28.5114.8% of flowCommon StockSEC:0001674335-21-000078
5,336 shares@ US$28.510.098% mcap14.8% of flowCommon StockSEC:0001674335-21-000078:0
4 of 4 declarations
About Farmakis Peter
Peter Farmakis is the EVP & President of Australasia at JELD-WEN Holding, Inc. In this role, he oversees the company's operations in the region, ensuring efficiency and growth of the business. JELD-WEN is a global leader in door and window manufacturing. Peter Farmakis brings strong management and business development experience, contributing to the company's expansion in the market.
